^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    Resimmune (A-dmDT390-bisFv(UCHT1))

    i
    Other names: A-dmDT390-bisFv(UCHT1), UCHT-1, A-dmDT390-anti-CD3 immunotoxin, A-dmDT390-bisFv, LAX-699
    Associations
    News
    Trials
    Company:
    AOP Orphan Pharma, Angimmune
    Drug class:
    Elongation factor 2 inhibitor, CD3 inhibitor
    Related drugs:
    Associations
    News
    Trials